Literature DB >> 18949330

Association of the presence of residual anti-Toxoplasma gondii IgM in pregnant women and their respective family groups in Miracema, Northwest Rio de Janeiro, Brazil.

Ana Claudia Ribeiro1, Martha Suarez Mutis, Octavio Fernandes.   

Abstract

The seroprevalence of toxoplasmosis in 832 pregnant women in Miracema, Rio de Janeiro, was determined and 75.1% (625) and 2.0% (17) were anti-Toxoplasma gondii IgG and IgM positive, respectively. Out of the 17 IgM positive pregnant women, only one had low avidity IgG corresponding to the acute phase of the infection. All the other women presented with high avidity IgG and also presented with residual IgM anti-T. gondii. Of this sample, 106 received home visits (this includes 11 family nuclei of pregnant women with residual IgM anti-T. gondii, 68 nuclei of only IgG positive pregnant women and 27 nuclei of pregnant women with no antibodies to anti-T. gondii), resulting in 267 individuals visited. Out of these 267 individuals, 21 were positive for IgG and IgM anti-T. gondii and were candidates for the IgG avidity test. All of them presented with high avidity IgG and residual IgM. Five of these IgM+ individuals were (5/238; 2.1%) relatives of IgM negative pregnant women. The other 16 (16/29; 55.2%) were relatives of IgM+ pregnant women who were positive for residual IgM anti-T. gondii. This association was statistically significant (p = 0.0000). The analysis presented herein raises questions regarding the presence of residual IgM anti-T. gondii such as genetic determinants or even constant antigenic stimuli for the same family cluster.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949330     DOI: 10.1590/s0074-02762008000600013

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

Review 1.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

2.  Knowledge of toxoplasmosis among doctors and nurses who provide prenatal care in an endemic region.

Authors:  Laura Berriel da Silva; Raquel de Vasconcelos Carvalhaes de Oliveira; Marizete Pereira da Silva; Wendy Fernandes Bueno; Maria Regina Reis Amendoeira; Elizabeth de Souza Neves
Journal:  Infect Dis Obstet Gynecol       Date:  2011-05-18

3.  Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.

Authors:  Aurélie Smets; Thomas Fauchier; Grégory Michel; Pierre Marty; Christelle Pomares
Journal:  Parasite       Date:  2016-10-20       Impact factor: 3.000

4.  Anti-Toxoplasma gondii antibodies in patients with beta-hemoglobinopathies: the first report in the Americas.

Authors:  Marina Neves Ferreira; Claudia Regina Bonini-Domingos; Isabeth Fonseca Estevão; Clarice Lopes de Castro Lobo; Gisele Cristina Souza Carrocini; Aparecida Perpétuo Silveira-Carvalho; Octávio Ricci; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2017-06-14

5.  Epidemiology and aetiology of maternal parasitic infections in low- and middle-income countries.

Authors:  Tom Roberts; Courtney A Gravett; Prasad Palani Velu; Evropi Theodoratou; Thor A Wagner; Jian Shayne F Zhang; Harry Campbell; Craig E Rubens; Michael G Gravett; Igor Rudan
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

6.  A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis.

Authors:  Mariana Previato; Fábio Batista Frederico; Fernando Henrique Antunes Murata; Rubens Camargo Siqueira; Amanda Pires Barbosa; Aparecida Perpétuo Silveira-Carvalho; Cristina da Silva Meira; Vera Lúcia Pereira-Chioccola; Ricardo Gava; Plínio Pereira Martins Neto; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2015-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.